6-K ·Filed Jun 1, 2026
Notable filing: 6-K
Actionable Insight • Neutral
Routine scheduling notice with no market-moving content. Monitor for any subsequent material disclosures from the investor meetings.
RDY drugs
RDY drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60Entry
$13.26
T+0 close · Jun 1, 2026 · via day close
Latest settled
−6.94%
T+60 · $12.34
Vs SPY
−8.17%
α at T+60
Horizons
All settled
through T+60
- T+0 · Jun 1 $13.26entry
- T+1 · 6mo ago −1.73%α −1.88% · $13.03
- T+5 · 5mo ago −0.15%α +2.60% · $13.24
- T+20 · 5mo ago +9.28%α +10.57% · $14.49
- T+60 · 3mo ago −6.94%α −8.17% · $12.34
Price Chart
REPLAYWatch the reaction play outLoading chart...
How similar events traded
Executive Summary
Dr. Reddy's filed a routine 6-K furnishing a notice of upcoming investor meetings with Bank of America on June 5, 2026. No material financial or operational information was disclosed.
Key Facts
- Management will participate in an in-person group meeting with Bank of America on June 5, 2026 in Hyderabad.
- No financial results, guidance, pipeline updates, or material corporate events are reported.
Financial Impact
No financial figures disclosed.
Market Snapshot
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
52% bullish (44 analysts)
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001575872-26-000386 |
| Document: 0001575872-26-000386-index.html | 0001575872-26-000386 |
| Document: 0001575872-26-000386.txt | 0001575872-26-000386 |
Track record
73 reports on RDY
7 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +23.28% at T+20 after the Jun 26, 2026 report. 7 of 12 went positive at some point.
Filters
- Nov 16, 2026today 6-K Bullish 4/10 Entry $14.85 Now $14.70 −1.01% settles Nov 23
- Nov 10, 20266d ago 6-K Neutral 2/10 Entry $14.86 Now $14.70 −1.08% settles Nov 17
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $15.05 to $14.70 Now $14.70 −2.33% ▼ −2.33% −0.63% vs SPY
- Nov 5, 202611d ago 6-K Neutral 4/10 Entry $14.53 to $14.73 Now $14.70 +1.17% ▲ +1.38% −1.91% vs SPY
- Nov 4, 202612d ago 6-K Neutral 2/10 Entry $14.77 to $14.84 Now $14.70 −0.47% ▲ +0.47% +1.39% vs SPY
- Nov 2, 202614d ago 144 Bearish 5/10 Entry $14.13 to $15.05 Now $14.70 −4.03% ▼ −6.51% −6.43% vs SPY
- Oct 29, 202618d ago 6-K Neutral 2/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
- Oct 28, 202619d ago 6-K Neutral 3/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
Showing 10 of 73
US Market Status
Market Closed · Opens in 5h 7m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers